Cargando…

Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model

BACKGROUND & OBJECTIVES: Considerable efforts are being made to develop new, more effective drugs for osteoporosis, including novel forms of bisphosphonates. The present study was carried out to compare the effect of a novel agent glucosamine alendronate (GA) alone and is combination with dihydr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muraleva, Natalya A., Ofitserov, Evgeniy N., Tikhonov, Vladimir P., Kolosova, Natalya G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336854/ https://www.ncbi.nlm.nih.gov/pubmed/22446865

Ejemplares similares

Bioavailability and Safety of Dihydroquercetin (Review)
por: Orlova, S. V., et al.
Publicado: (2022)

Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
por: Xiong, Zhencheng, et al.
Publicado: (2022)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Research Progress of Dihydroquercetin in the Treatment of Skin Diseases
por: Liu, Ziyang, et al.
Publicado: (2023)

Sequential treatment of teriparatide and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a prospective study
por: Yang, Dazhi, et al.
Publicado: (2023)

Solubility Enhancement of Dihydroquercetin via “Green” Phase Modification
por: Terekhov, Roman P., et al.
Publicado: (2022)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Comparing the effect of Glucosamine and Glucosamine With Alendronate in Symptomatic Relieve of Degenerative Knee Joint Disease: A Double- blind Randomized Clinical Trial Study
por: Arti, Hamid Reza, et al.
Publicado: (2012)

Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis
por: Permuy, María, et al.
Publicado: (2014)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Skin Penetration Enhancement by Natural Oils for Dihydroquercetin Delivery
por: Čižinauskas, Vytis, et al.
Publicado: (2017)

Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit
por: Alam, Qadir, et al.
Publicado: (2022)

Engineering Saccharomyces cerevisiae for the production of dihydroquercetin from naringenin
por: Yu, Shiqin, et al.
Publicado: (2022)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
por: Li, Mei, et al.
Publicado: (2022)

Research on Characteristics, Antioxidant and Antitumor Activities of Dihydroquercetin and Its Complexes
por: Zhang, Yan, et al.
Publicado: (2017)

Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications
por: Terekhov, R. P., et al.
Publicado: (2021)

Exploring the genes involved in biosynthesis of dihydroquercetin and dihydromyricetin in Ampelopsis grossedentata
por: Yu, Zheng-Wen, et al.
Publicado: (2021)

Effect of Dihydroquercetin on Energy Metabolism in LPS-Induced Inflammatory Mice
por: Yu, Xiaoying, et al.
Publicado: (2022)

Unraveling the Antioxidant Activity of 2R,3R-dihydroquercetin
por: Xu, Yaping, et al.
Publicado: (2023)

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
por: Mori, Satoshi, et al.
Publicado: (2022)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax(®)) for osteoporosis treatment
por: Unnanuntana, Aasis, et al.
Publicado: (2017)

Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
por: Jain, Sumit Kumar, et al.
Publicado: (2011)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
por: Ahn, Guk Young, et al.
Publicado: (2021)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012)

Toxicity of Silver Nanoparticles Supported by Surface-Modified Zirconium Dioxide with Dihydroquercetin
por: Sredojević, Dušan, et al.
Publicado: (2022)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia
por: Lila, Alexander M, et al.
Publicado: (2023)

Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
por: Deng, Jing, et al.
Publicado: (2018)

A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015)

Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
por: Kim, Kwang Joon, et al.
Publicado: (2014)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
por: Calabria, S, et al.
Publicado: (2016)

How Efficient are Alendronate-Nano/Biomaterial Combinations for Anti-Osteoporosis Therapy? An Evidence-Based Review of the Literature
por: Klara, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ivgbo3t0f6aumrmec2bqhsbg0g